Alphamab Oncology files HKEX next-day disclosure return after share repurchase

PUBT · 1d ago
Alphamab Oncology files HKEX next-day disclosure return after share repurchase
  • Alphamab Oncology filed an HKEX next-day disclosure return covering a 123,000-share on-market buyback on Sept. 11, 2026.
  • Shares were repurchased for treasury at HKD 7.85–8 per share; volume-weighted average price HKD 7.95.
  • Aggregate consideration was HKD 977,540; no shares were repurchased for cancellation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260911-12329657), on September 11, 2026, and is solely responsible for the information contained therein.